Heerma Peter (CIK 0001789617)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: CHIEF COMMERCIAL OFFICER
Shares held
117,993
Last filed at
Nov 4, 2025
Confidence Score
32.4
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 31, 2025 Nov 4, 2025 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 32.5 -6,669 -5.35% ✓ $195.7K
Oct 28, 2025 Oct 30, 2025 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 41.3 -2,662 -2.09% ✓ $79.9K
May 2, 2025 May 5, 2025 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 46.3 -1,771 -1.36% ✗ $37.3K
Feb 10, 2025 Feb 12, 2025 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 37.5 -5,642 -4.32% ✓ $137.3K
Jan 31, 2025 Feb 4, 2025 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 95.0 +16,334 15.36% ✗ $103.9K
Jan 22, 2025 Jan 23, 2025 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 46.3 -1,584 -1.47% ✗ $30K
Sep 5, 2024 Sep 9, 2024 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 83.8 +4,559 4.41% ✗ $25.2K
Jan 31, 2024 Feb 2, 2024 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 91.3 +20,805 26.44% ✗ $35.8K
Jan 23, 2024 Jan 25, 2024 Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Sell 46.3 -1,559 -1.94% ✗ $14.1K
Oct 3, 2023 Oct 4, 2023 Travere Therapeutics, Inc. Chief Commercial Officer Sell 46.3 -3,091 -3.71% ✗ $25.5K
Jan 31, 2023 Feb 2, 2023 Travere Therapeutics, Inc. Chief Commercial Officer Sell 91.3 +18,471 29.04% ✗ $38.7K
Jan 24, 2023 Jan 26, 2023 Travere Therapeutics, Inc. Chief Commercial Officer Sell 46.3 -1,550 -2.38% ✗ $34K
Oct 4, 2022 Oct 6, 2022 Travere Therapeutics, Inc. Chief Commercial Officer Sell 42.5 -3,042 -4.46% ✗ $78.1K
Jan 31, 2022 Feb 2, 2022 Travere Therapeutics, Inc. Chief Commercial Officer Sell 91.3 +8,715 14.88% ✓ $30.8K
Jan 24, 2022 Jan 26, 2022 Travere Therapeutics, Inc. Chief Commercial Officer Sell 41.3 -1,875 -3.10% ✓ $46.8K
Oct 4, 2021 Oct 5, 2021 Travere Therapeutics, Inc. Chief Commercial Officer Sell 42.5 -3,058 -4.81% ✗ $75.7K
Aug 13, 2021 Aug 17, 2021 Travere Therapeutics, Inc. Chief Commercial Officer Sell 86.3 +3,093 5.12% ✗ $24.1K
Feb 5, 2021 Feb 9, 2021 Travere Therapeutics, Inc. Chief Commercial Officer Sell 37.5 -2,250 -3.65% ✓ $70.9K
Feb 2, 2021 Feb 3, 2021 Travere Therapeutics, Inc. Chief Commercial Officer Sell 48.8 -1,126 -1.93% ✓ $33.6K
Oct 2, 2020 Oct 5, 2020 Travere Therapeutics, Inc. Chief Commercial Officer Sell 28.8 -4,376 -9.37% ✓ $83.7K